https://twitter.com/VigilantFox/status/1776023843888415125

The Vigilant Fox 🦊
@VigilantFox

100% Cancer Remission Achieved in ALL Patients of Groundbreaking Study
Dr. Andrea Cercek, one of the lead researchers, said:
“It’s absolutely incredible … We’ve certainly never seen this before.”

All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody.

This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies.

The authors wrote:

“All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging … and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.”